U.S. Mortgage REITs Stock News

Deciding what to do with Bristol-Myers Squibb stock right now might feel like a coin toss, but there is more than luck at play. The stock closed recently at $47.15, and if you have been watching the rollercoaster of news out of Washington and Brussels, you know the ride has been eventful. Over the past year, the share price has moved up just 1.6%, with more dramatic swings when you zoom out and in: it is down 17.0% year-to-date and has dropped 24.0% over the last three years. So what is...

ARS Pharmaceuticals (SPRY) is catching investor attention this week after sharing real-world clinical data that puts its flagship product, neffy, squarely in the spotlight. Unlike traditional epinephrine injections, neffy is a needle-free nasal spray aimed at treating anaphylaxis. The company announced that neffy demonstrated an 89.2% success rate in 545 patients, very close to what is seen with the tried-and-true injection method. The findings, now accepted for publication in a leading...

What’s Behind Viking Therapeutics' Recent Moves? If you hold shares of Viking Therapeutics (VKTX) or are thinking about jumping in, the stock’s roller-coaster ride this year is hard to ignore. With no single event triggering the latest price action, the subtle shifts in VKTX’s value are drawing attention. Investors are left wondering if the market is signaling something new about the company’s prospects or just recalibrating after a stretch of volatility. Even without a headline-grabbing...

On September 9, 2025, Cboe Global Markets announced plans to launch Cboe Continuous futures for bitcoin and ether on its U.S. futures exchange, pending regulatory review. This move introduces single, long-dated, cash-settled contracts with daily spot price alignment, aiming to simplify digital asset exposure and risk management for U.S. traders. We'll explore how the introduction of Cboe Continuous futures in digital assets could influence the long-term investment outlook for the company. AI...

Freddie Mac recently announced the pricing of its second Seasoned Credit Risk Transfer Trust (SCRT) offering of 2025, involving the securitization of about US$707 million in seasoned re-performing loans with both guaranteed senior and non-guaranteed subordinate securities. This securitization marks a significant move in Freddie Mac’s approach to managing less-liquid assets and mitigating credit and market risk in its investment portfolio. To assess the impact on Freddie Mac’s investment...

In recent days, analysts have shown strong agreement that Sezzle will report earnings surpassing previous estimates and have upgraded its ranking to reflect this optimism. This surge in analyst confidence highlights a growing belief in Sezzle's near-term financial outlook among investment professionals. We'll now explore what rising analyst optimism and stronger earnings expectations might mean for Sezzle's broader investment narrative. Trump's oil boom is here - pipelines are primed to...

Trying to figure out if now’s the right moment to buy, sell, or just sit tight with Amazon.com stock? You’re hardly alone. Amazon continues to draw the attention of investors, and with good reason. Over the past year, shares have popped by 24.8%. Looking farther back, a 79.2% gain in the last three years showcases the kind of long-term performance that keeps Amazon in the spotlight. More recent moves, including a 1.9% lift just in the last week, make it tough to ignore for those watching...

DocuSign recently reported its second quarter earnings, showing year-over-year revenue growth to US$800.64 million but a substantial drop in net income to US$62.97 million, along with updates to its board of directors and a completed share buyback tranche. The company’s new board appointments, including a CEO and seasoned finance executive as board chair, may signal shifts in governance and future strategic direction. We'll examine how DocuSign's weaker net income alongside governance...

ZEEKR Intelligent Technology Holding Limited announced that in August 2025, it delivered 44,843 vehicles across its Zeekr and Lynk & Co brands, marking increases of 10.6% year-over-year and 1.5% compared to the previous month. This solid performance, paired with the unveiling of new hybrid technologies and the upcoming Zeekr 9X model, underscores the company's ongoing push to enhance innovation and broaden its customer reach in the electric vehicle sector. We'll now examine how August's...

If you have been watching TransUnion (TRU) lately, the company’s shares just made a decisive move higher. The catalyst? TransUnion announced a strategic partnership with Truework to ramp up distribution and coverage for income and employment verification solutions, leveraging an earlier minority stake in Truework. This collaboration is being promoted as a way to provide broader, more efficient verification coverage for lenders and streamline the process for consumers, potentially boosting...

If you have been watching Veritone (VERI) lately, the latest surge in attention is easy to understand. D. Boral Capital just delivered a substantial analyst upgrade, spotlighting the company’s Data Refinery business and its ongoing pivot toward government and law enforcement contracts. The buzz grew after Veritone highlighted new projects and a much larger pipeline at a recent investment conference, sparking some big questions about what’s ahead for shareholders. This comes after a year...

TAT Technologies (NasdaqGM:TATT) is catching investors’ attention this week, and it is easy to see why. The company has announced the launch of FutureWorks, a new Center for Aerospace Innovation based in Charlotte, North Carolina. This event goes beyond a traditional ribbon-cutting, as TAT has also revealed its first customer partnership for its advanced thermal management systems. The message is clear: TAT’s push into next-generation aerospace solutions is now validated in the real world and...

REV Group, Inc. recently reported third quarter results showing year-over-year growth in sales to US$644.9 million and net income to US$29.1 million, while also raising its full-year earnings guidance and affirming a regular quarterly cash dividend of US$0.06 per share, payable in October 2025. The company signaled ongoing interest in disciplined acquisitions to complement internal investments and announced completion of its previously authorized share buyback program, further reflecting its...

Clover Health Investments (CLOV) is making headlines again, this time with the introduction of a new AI-powered scribing tool on its Counterpart Assistant platform. This move is more than just another tech update; it could have real implications for how efficiently smaller practices operate and how Clover Health is positioned in the competitive healthcare technology space. Recent analyst commentary has also highlighted improved ratings for the company’s Medicare Advantage plans, progress in...

Microbot Medical has grabbed the spotlight with news that could shift the company’s direction in a major way. After securing FDA 510(k) clearance for its LIBERTY Endovascular Robotic System, the first single-use, remotely operated device approved for peripheral endovascular procedures, the company is now cleared to commercialize this breakthrough technology in the U.S. market. By removing the typical hurdles of expensive capital equipment and specialized infrastructure, LIBERTY could give...

LGI Homes (LGIH) has been quietly catching some attention recently, especially among investors wondering if the current stock movement signals something bigger ahead. There has not been a single defining event to push shares in either direction. Whenever a stock makes noticeable moves without an obvious trigger, it tends to spark curiosity about what the market might be anticipating. In the case of LGI Homes, this is a moment where investors are pausing to ask if there is an underlying story...

Northrop Grumman (NOC) has caught investor attention again this week, even in the absence of headline-making news or a specific market-moving event. Sometimes, these quieter stretches can be just as interesting, prompting thoughtful investors to look closer. Did something change beneath the surface, or is the market simply reassessing the company’s longer-term prospects? For shareholders, these periods often signal an opportunity to reassess valuation and refocus on fundamentals. Looking at a...

Imperial Petroleum (NasdaqCM:IMPP) just released its Q2 2025 earnings, shining a spotlight on both its strengths and recent challenges. Investors may already know that the company's reported sales and net income declined compared to last year. Second quarter revenue dropped to $36.35 million from $47.04 million, and net income dipped to $12.76 million from $19.52 million. These numbers can prompt a pause, especially for anyone weighing whether management’s long-term strategy is hitting a...

If you’re debating what to do with StepStone Group (STEP) after recent headlines, you’re not alone. The company has just teamed up with Kroll to unveil the Kroll StepStone Private Credit Benchmarks, a first-of-its-kind tool designed to bring sharper insights to a traditionally opaque sector. For investors attuned to the importance of market transparency, this move could have big implications for how private credit is valued and understood. This new benchmark initiative appears to be...

In recent days, TAL Education Group reported a price-to-earnings ratio of 60.5x and earnings per share growth of 97% last year, with analysts projecting annual earnings growth of 53% over the next three years. This strong outlook has spotlighted TAL’s rapidly expanding earnings expectations, reflecting renewed investor confidence in the company’s long-term growth prospects and market positioning. We'll explore how analysts' expectations for outsized future earnings growth influence TAL...

On September 9, 2025, Xometry released its first-ever Manufacturing Outlook report, spotlighting significant industry trends such as the prioritization of artificial intelligence, widespread adoption of reshoring, and anticipated price increases among manufacturers for 2026. A unique insight from the report is that 82% of manufacturing executives now view AI as a key driver of growth, with nearly half already reporting meaningful returns on their AI investments. We’ll explore how the broad...

The Chemours Company recently announced that Mary Cranston has been appointed Chair of the Board and Alister Cowan as Lead Independent Director, following Dawn Farrell's resignation to lead the Canadian government's Major Projects Office. Cranston's extensive governance background and her role in Board refreshment are expected to influence Chemours' long-term strategy and board oversight priorities. We'll explore how Cranston's leadership and board experience may impact Chemours' investment...

Thinking about what to do next with NANO Nuclear Energy (NNE)? The company just landed a Direct to Phase II Small Business Innovation Research contract from AFWERX, the U.S. Air Force's innovation hub. This project focuses on developing NANO Nuclear’s advanced KRONOS MMR Energy System at Joint Base Anacostia-Bolling in Washington, D.C. It is a solid endorsement of the company’s technology for military use and could accelerate how quickly its microreactors progress from drawing board to...

In recent months, SiteOne Landscape Supply experienced a shift in analyst sentiment, with expectations for improved earnings growth rates despite ongoing operational challenges and below-industry financial metrics. This optimism among analysts has emerged even as SiteOne continues to report a lower return on equity and declining earnings compared to broader industry trends. We'll examine how renewed confidence in SiteOne's earnings outlook may influence its broader investment narrative and...